The CMT Research Foundation's Emerging Researcher Award funds innovative early-career research projects to overcome key scientific barriers in Charcot-Marie-Tooth drug development.
Funder: CMT Research Foundation
Due Dates (Anticipated): December 2026: Optional Letter of Intent deadline (projected) | December 2026: Optional Letter of Intent deadline (YRIG historical pattern; projected) | December 2026: Full proposal submission deadline (CMTRF general cycle; projected) | February 2027: Full application deadline (Emerging Researcher Award historical date; projected) | February 2027: Full proposal submission deadline (CMTRF general cycle; projected) | February 2027: Full application submission deadline (YRIG historical pattern; projected) | May 2027: Full proposal submission deadline (CMTRF general cycle; projected)
Funding Amounts: Pilot Grant: up to $75,000 for 1 year; Predoctoral Grant: up to $25,000 for 1 year; indirect costs capped at 10%.
Summary: Supports early-career researchers and trainees conducting innovative, high-impact research to overcome key barriers in Charcot-Marie-Tooth (CMT) drug development.
The Emerging Researcher Award, offered by the CMT Research Foundation (CMTRF), is designed to empower promising young scientists and early-career investigators to address critical barriers in Charcot-Marie-Tooth (CMT) drug development. The program funds small, high-impact research projects that generate preliminary data necessary for launching larger therapeutic initiatives. Two types of grants are available: Predoctoral Grants for current PhD/MD students and Pilot Grants for postdoctoral fellows and early-career investigators in academia or industry. The award strongly encourages innovative approaches, collaborative research, and projects that focus on target validation, model development, drug delivery, and proof-of-concept strategies to accelerate CMT therapeutic progress.